ClinicalTrials.Veeva

Menu

ST250 as a Therapeutic Option for Head & Neck Reconstruction

A

Alaa Emara

Status and phase

Not yet enrolling
Phase 2
Phase 1

Conditions

Tonsillitis

Treatments

Other: Comparator
Device: SupraTHEL 250

Study type

Interventional

Funder types

Other

Identifiers

NCT06543823
ST250 mucosal application

Details and patient eligibility

About

To assess the use of SupraThel 250 for mucosal reconstruction in the Head & Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing

Full description

After tonsillectomy procedures, the wound is usually left bare to heal. This causes severe pain postoperatively and postoperative hemorrhage. SupraTHEL 250 is a synthetic biodegradable PLA membrane which is proven as a skin membrane in burn wounds with excellent result. We therefore hypothesize that the use opf SupraTHEL 250 after tonsillectomy procedures will allow for faster , less painful healing of the wound bed which allows for a better quality of life for the patients.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • recurrent episodes of tonsillar infection

Exclusion criteria

  • children
  • pregnant/ breastfeeding women
  • patients undergoing chemo / radiotherapy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Study group
Sham Comparator group
Description:
The wound bed is left bare after the tonsillectomy procedure
Treatment:
Other: Comparator
SupraTHEL 250 group
Experimental group
Description:
The SupraTHEL 250 membrane is suture ionto the wound bed after the tonsillectomy procedure
Treatment:
Device: SupraTHEL 250

Trial contacts and locations

0

Loading...

Central trial contact

Alaa Emara

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems